| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | - | - | 0 | 0 | 15.120 | 29.351 | 44.149 | 115.517 |
| Total Income - EUR | 0 | 0 | - | - | 0 | 0 | 15.120 | 29.361 | 44.149 | 115.517 |
| Total Expenses - EUR | 9 | 0 | - | - | 0 | 0 | 701 | 2.973 | 12.729 | 19.956 |
| Gross Profit/Loss - EUR | -9 | 0 | - | - | 0 | 0 | 14.419 | 26.389 | 31.421 | 95.560 |
| Net Profit/Loss - EUR | -9 | 0 | - | - | 0 | 0 | 13.965 | 25.670 | 30.988 | 92.164 |
| Employees | 0 | 0 | - | - | 0 | 0 | 0 | 0 | 1 | 0 |
Check the financial reports for the company - Medviva Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 67 | 67 | - | - | 63 | 62 | 50 | 7.714 | 11.845 | 12.562 |
| Current Assets | 284 | 281 | - | - | 266 | 261 | 12.862 | 27.711 | 43.944 | 96.952 |
| Inventories | 0 | 0 | - | - | 0 | 261 | 0 | 0 | 0 | 0 |
| Receivables | 284 | 281 | - | - | 266 | 0 | 5.481 | 24.083 | 41.802 | 91.056 |
| Cash | 0 | 0 | - | - | 0 | 0 | 7.381 | 3.629 | 2.142 | 5.896 |
| Shareholders Funds | -1.730 | -1.712 | - | - | -1.621 | -1.590 | 12.411 | 25.719 | 31.037 | 92.212 |
| Social Capital | 45 | 45 | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.082 | 2.060 | - | - | 1.950 | 1.913 | 501 | 9.706 | 24.752 | 18.210 |
| Income in Advance | 0 | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medviva Srl